Legal Representation
Attorney
Cristina Arenas Solis
USPTO Deadlines
Next Deadline
937 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-02-27)
Due Date
February 27, 2028
Grace Period Ends
August 27, 2028
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 9, 2024 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
| Feb 27, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Feb 27, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 12, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 12, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 22, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 5, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 25, 2017 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 25, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 25, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 25, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 25, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 11, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 20, 2017 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 19, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 15, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Design Mark
The mark consists of the word "ÉTERNELLE" in upper case letters. Beneath it, the word "PHARMA" appears in smaller font between two horizontal lines. Above "ÉTERNELLE", there appears a wreath inside a square shape with curved sides.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English Translation of the word "ÉTERNELLE" in the mark is "ETERNAL".
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"